Chiliz Group Ltd. - 13 Feb 2026 SCHEDULE 13D/A Report for Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PCSA)

Filing Manager
Chiliz Group Ltd.
Reporting Manager
HX Entertainment Ltd
Security
Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
PCSA
Shares outstanding
2,351,108 shares
Disclosed Ownership
305,644 shares
Ownership
13%
Form type
SCHEDULE 13D/A
Filing time
23 Feb 2026, 11:00:19 UTC
Date of event
13 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Chiliz Group Ltd. disclosed 13% ownership in Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PCSA) on 13 Feb 2026."

Quick Takeaways

  • Chiliz Group Ltd. filed SCHEDULE 13D/A for Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PCSA).
  • Disclosed ownership: 13%.
  • Date of event: 13 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Feb 2026, 11:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
HX Entertainment Ltd 13% 305,644 305,644 0 X Alexandre Dreyfus 0002081456

Sponsored